New 6-Month TB drug combo could replace Year-Long ordeal
NCT ID NCT07486024
First seen Mar 27, 2026 · Last updated Apr 29, 2026 · Updated 6 times
Summary
This study tests a new 6-month treatment called BPaLM for people with multidrug-resistant tuberculosis (MDR-TB) in France. It aims to see if this shorter regimen works as well as the standard long treatment that can last over a year. About 55 adults with confirmed MDR-TB will receive BPaLM, and their outcomes will be compared to past patients who had the longer treatment. Success is measured by curing the infection without needing extra drugs or long breaks in therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYCOBACTERIUM TUBERCULOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Pitié-Salpêtrière Hospital - infectious and tropical diseases
Paris, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.